Bonaventura, I.
Tomaselli, A.
Angelini, F.
Ferrari, D.
De Alcubierre, D.
Hasenmajer, V.
Sbardella, E.
Cozzolino, A.
Paganini, A. M.
Isidori, A. M.
Minnetti, M.
Pofi, R. http://orcid.org/0000-0001-7808-5735
Funding for this research was provided by:
Italian Ministry of University and Research under PNRR (B53C22004000006)
Article History
Received: 27 August 2023
Accepted: 14 December 2023
First Online: 22 February 2024
Declarations
:
: AMI disclose principal investigator role in sponsored trials and consultancies for Recordati, Corcept, HRA pharma, Neurocrine<i>.</i> All the other authors have no relevant financial or non-financial interests to disclose.
: The study was approved by the Ethics Committee of Sapienza University in Rome (reference number 5279).
: The study was conducted in accordance with the Declaration of Helsinki, and all participants gave their written informed consent to participate in the study and to publish the data.